Delivery Order SPE2DB24D3013-SPE2DB25FFQGN
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Simvastatin 20 mg tablets (1,000 count) under a firm fixed price contract valued at $3,600.95. This competitively awarded, non-set-aside delivery order was issued on September 3, 2025, with an ultimate completion date of September 4, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 22, 2025, for the supply of Simvastatin 20 mg tablets in a quantity of 1,000 units, with a contract ceiling value of $1,029.20. This is a firm fixed price delivery order with no set-aside designation, indicating the award was competitively procured. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order falls...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Simvastatin 20 mg tablets in quantities of 1,000 units. This competitively awarded, non-set-aside delivery order carries a ceiling value of $2,539.58 and is structured as a firm fixed price contract with an ultimate completion date of August 26, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Simvastatin 40 mg tablets in quantities of 1,000 units, with a contract ceiling value of $2,247.54. This competitively awarded, firm fixed-price delivery order has an ultimate completion date of August 11, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award utilizes no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $1,153.38 to AmerisourceBergen Drug Corp for 1,000 tablets of Simvastatin 40 mg, a widely prescribed generic statin medication used to manage cholesterol levels in military and veteran healthcare populations. This competitively awarded, firm fixed-price contract was executed on August 18, 2025, with an ultimate completion date of August 19, 2025, and represents a routine pharmaceutical procurement fulfilled from the vendor's place...
- The Defense Logistics Agency awarded a delivery order valued at $1,116.54 to AmerisourceBergen Drug Corp for 1,000 tablets of Simvastatin 20 mg, a generic statin medication used to manage cholesterol levels. The award was made on April 25, 2025, with an ultimate completion date of April 28, 2025. This delivery order represents a firm fixed price contract with no set-aside designation, indicating the award was made through open competition. The place of performance is AmerisourceBergen's...
- This federal contract award is for the delivery of 4,562,331,338 units of SIMVASTATIN 20 MG TABLET 1000S, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The fixed-price delivery order, valued at $2,140.68, has an ultimate completion date of September 28, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is the prime contractor for this award, which is a part of the...
- The federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Simvastatin 20 mg tablets. The contract, valued at $14,131.81, is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract has an ultimate completion date of September 5, 2023 and is a firm fixed-price contract type. Amerisourcebergen Drug Corp is a subsidiary of the...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,326.92, is for the delivery of Simvastatin 40 mg tablets in quantities of 1,000. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of November 30, 2023. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
- The Defense Logistics Agency awarded a $414,630 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 1,000 bottles of 20mg Simvastatin tablets. The prime contractor will deliver the generic cholesterol-lowering medication from its Conshohocken, Pennsylvania facility to support the Department of Defense's medical supply needs. No subcontractors or set aside designations were identified. This type of small purchase supports the DLA's mission to provide medical supplies to...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFQGNDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,045.70 to AmerisourceBergen Drug Corp for the supply of Simvastatin 20 mg tablets (1,000 count) with an ultimate completion date of September 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, fulfills this order under its existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. This delivery order represents a routine pharmaceutical supply transaction supporting the Department of Defense's medical supply chain requirements. As a prime vendor under the DLA Troop Support Medical IDC, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceutical products and medical commodities to support military healthcare programs and other federal health systems, including the Defense Health Agency and U.S. Coast Guard. The firm fixed-price structure and competitive award reflect the company's established capability to meet federal pharmaceutical procurement standards through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 9/5/25 |